Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 2
Submit an article Journal homepage
313
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia

Minghua CaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USA
,
Ruben D. CarrascoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USA
,
Adrian M. DubucDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USA
,
Paola Dal CinDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USA
,
Jonathan A. FletcherDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USA
&
Sheng XiaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston (MA), USACorrespondence[email protected]
Pages 556-558 | Received 24 Apr 2018, Accepted 19 Jun 2018, Published online: 30 Aug 2018

References

  • Han JY, Theil KS. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction. Cancer Genet Cytogenet. 2006;165:70–74.
  • Quintás-Cardama A, Gibbons DL, Cortes J, et al. Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia. Leukemia. 2008;22:877–878.
  • Shah N, Leaker MT, Teshima I, et al. Late-appearing Philadelphia chromosome in childhood acute myeloid leukemia. Pediatr Blood Cancer. 2008;50:1052–1053.
  • Strati P, Tang G, Duose DY, et al. Myeloid/lymphoid neoplasms with FGFR1 rearrangement. Leukemia and Lymphoma. 2017;9:1–5.
  • Kumar KR, Chen W, Koduru PR, et al. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: A case report and review of literature. Amer J Clin Pathol. 2015;143:738–748.
  • Gröschel S, Sanders MA, Hoogenboezem R, et al. Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways. Blood. 2015;125:133–139.
  • Xiao S, McCarthy JG, Aster JC, et al. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood. 2000;96:699–704.
  • Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol. 2002;107:101–107.
  • Pini M, Gottardi E, Scaravaglio P, et al. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J. 2002;3:315–316.
  • Helsten T, Elkin S, Arthur E, et al. The FGFR landscape in cancer: Analysis of 4,853 tumors by next-generation sequencing. Clin Cancer Res. 2016;22:259–267.
  • Chen J, Deangelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA. 2004;101:14479–14484.
  • Kreil S, Adès L, Bommer M, et al. Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes. Blood. 2015;126:2812.
  • Chae YK, Ranganath K, Hammerman PS, et al. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application. Oncotarget. 2017;8:16052–16074.
  • Verstovsek S, Subbiah V, Masarova L, et al. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 Inhibitor. Ann Oncol. 2018. DOI:10.1093/annonc/mdy173

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.